FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 194 filers reported holding FIBROGEN INC in Q1 2020. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $45,719 | -69.9% | 16,933 | +13.7% | 0.00% | -25.0% |
Q3 2021 | $152,000 | -49.5% | 14,895 | +31.8% | 0.00% | -55.6% |
Q2 2021 | $301,000 | +201.0% | 11,300 | +362.9% | 0.01% | +80.0% |
Q3 2020 | $100,000 | -43.8% | 2,441 | -44.5% | 0.01% | -50.0% |
Q2 2020 | $178,000 | +513.8% | 4,400 | +559.7% | 0.01% | +900.0% |
Q4 2019 | $29,000 | +1350.0% | 667 | +1135.2% | 0.00% | – |
Q3 2019 | $2,000 | -99.3% | 54 | -98.9% | 0.00% | -100.0% |
Q1 2019 | $277,000 | +31.3% | 5,100 | +11.5% | 0.02% | +6.7% |
Q4 2018 | $211,000 | +224.6% | 4,572 | +338.4% | 0.02% | +275.0% |
Q2 2018 | $65,000 | -20.7% | 1,043 | -39.4% | 0.00% | -42.9% |
Q4 2017 | $82,000 | -31.7% | 1,722 | -22.9% | 0.01% | -36.4% |
Q3 2017 | $120,000 | -84.9% | 2,233 | -94.2% | 0.01% | -86.9% |
Q3 2016 | $797,000 | +962.7% | 38,500 | +737.0% | 0.08% | +740.0% |
Q2 2016 | $75,000 | +13.6% | 4,600 | +48.4% | 0.01% | +11.1% |
Q1 2016 | $66,000 | -13.2% | 3,100 | +24.0% | 0.01% | -25.0% |
Q4 2015 | $76,000 | – | 2,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |